European Archives - Page 3 of 1349 - European Medical Journal

asthma anxiety

Asthma Anxiety Reduced with Therapist-Guided Internet CBT

Therapist-guided internet CBT safely lowers asthma-related anxiety and boosts quality of life, control, and behaviour in adults with asthma.

neuroimaging

Neuroimaging Findings in Recreational Substance Use

Recreational substance use is associated with a broad range of neuroimaging findings, and radiologists play a key role in recognising patterns that influence emergency management and prognosis.

Mediterranean diet

Mediterranean Diet When Young Lowers Parkinson’s Risk in Women

Long-term research links Mediterranean diet patterns with lower Parkinson’s incidence in women younger than seventy one years.

fatigue

Baseline Fatigue Predicts Cancer Treatment Toxicity

Baseline fatigue reported at treatment initiation is associated with a significantly increased risk of severe, life threatening, and fatal cancer treatment related toxic effects.

Diabetes Drug Metformin Shows Potential in Osteoarthritis Care

Evidence from a clinical trial and long-term cohort studies suggests metformin, widely used in diabetes, may reduce knee osteoarthritis pain and lower future osteoarthritis risk.

ALA-DAG Oil

ALA-DAG Oil Improves Skin Hydration and Allergy Symptoms

ALA-DAG oil improved skin hydration and reduced allergic symptoms in adults with mild skin discomfort.

COVID-19: Not Gone, Just Gaining Ground Again

This comprehensive webinar brings together infectious disease specialists Andrew Ustianowski and Jacob Malin to discuss the current state…

Squamous Anal Cancer and CRC: From Diagnosis to Emerging Therapies

This Industry Satellite Symposium from ESMO 2025 brings together four leading experts, Sheela Rao, Christelle de la Fouchardière , Gunnar…

Advances in AD Outcomes

This promotional content is funded by Leo Pharma and is intended for healthcare professionals only. The medicinal product mentioned in…

Person looking into distance with telescope at arrow pointing upwards

UK clinical trial applications on the rise, finds MHRA

The 9% growth in 2025 could signal that the country is on track to become a more attractive destination for pharamceutical R&D.